尤超, 顾雅佳, 彭卫军, et al. MRI in the differential diagnosis of breast ductal cancerin situ[J]. China Oncology, 2014, 24(6): 463-468. DOI: 10.3969/j.issn.1007-3969.2014.06.011.
MRI in the differential diagnosis of breast ductal cancerin situ
背景与目的:乳腺导管原位癌(ductal carcinoma in situ,DCIS)属于乳腺浸润性癌的前驱病变,是一类非全身性的导管内局部病变,与其他导管内病变在影像上存在相似之处。本研究旨在探讨乳腺MRI鉴别诊断DCIS与其他乳腺导管内病变的价值。方法:回顾性分析2011年7月—2012年2月于复旦大学附属肿瘤医院行乳腺MRI检查并经手术病理证实的DCIS患者24例、DCIS伴微浸润(breast ductal carcinoma in situ with microinvasion,DCIS-MI)9例、乳腺导管内乳头状瘤(breast intraductal papilloma,BIDP)20例临床资料。以DCIS为研究主体,分析3种病变MRI及动态增强表现。结果:DCIS与DCIS-MI的病灶强化形态、强化方式、时间-信号强度曲线(TIC)、病灶伪彩图像间差异均无统计学意义(P>0.05),而DCIS与BIDP的病灶强化形态、强化方式、TIC、病灶伪彩图像间差异均有统计学意义(P<0.05)。DCIS以导管样(8/24)及段样强化(6/24)为主、病灶伪彩图像为红色(22/24)、TIC以Ⅲ型(12/24)为主要特征性表现;BIDP以乳头后局灶性强化为主(13/20)、病灶伪彩图像为非红色(14/20)、TIC以Ⅱ型(11/20)为主要特征性表现。结论:MRI较难鉴别DCIS与DCIS-MI,但具有鉴别诊断DCIS与BIDP的价值。
Abstract
Background and purpose: Ductal carcinoma in situ (DCIS)
is precursor lesions of invasive breast cancer
belongs to non-systemic ductal lesions
which is similar to other ductal lesions on imaging. This study aimed to investigate the differential diagnostic value of MRI in DCIS between DCIS with microinvasion (DCIS-MI) and breast intraductal papilloma (BIDP). Methods: All the cases were surgico-pathologically confirmed. Twenty-four patients were DCIS
9 patients were DCIS-MI
and 20 patients were BIDP. The MRI charateristics of DCIS
DCIS-MI and BIDP were analyzed and compared. Results: DCIS and DCIS-MI’s performance in the form of MRI is difficult to differentiate (P0.05). Compared with BIDP
the ductal and segmental enhancement
type Ⅲ time-signal intensity curve (TIC)
and the red pseudo-color image were associated with the DCIS. The local area enhancement
type Ⅱ TIC
and no-red pseudo-color image were associated with BIDP. Conclusion: MRI is a useful for differentiate between DCIS and BIDP
Risk factors of pathological underestimation in breast ductal carcinoma in situ diagnosed by ultrasound-guided core needle biopsy
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Exploration of the efficacy and safety of indocyanine green in the evaluation and localization of breast cancer surgical margins: a single-center, observational cohort study
Artificial intelligence in gastric cancer diagnosis, treatment and prognostic prediction: current application and future perspective
Advances and controversies in new techniques of breast pathology
Department of Thyroid and Breast Surgery, The Fourth Affiliated Hospital of Anhui Medical University (Affiliated Chaohu Hospital)
Pathology Department, The Fourth Affiliated Hospital of Anhui Medical University (Affiliated Chaohu Hospital)
General Practice, Hefei First People’s Hospital
Department of Oncology, Xinjiang Military Region General Hospital of the Chinese People’s Liberation Army, Urumqi 830000, Xinjiang Uygur Autonomous Region